RESUMO
Human immunodeficiency virus (HIV) type 1 Vpu is an integral membrane protein with a unique affinity for betaTrCP (TrCP), a key member of the SkpI-Cullin-F-box E3 ubiquitin ligase complex that is involved in the regulated degradation of cellular proteins, including IkappaB. Remarkably, Vpu is resistant to TrCP-mediated degradation and competitively inhibits TrCP-dependent degradation of IkappaB, resulting in the suppression of nuclear factor (NF)-kappaB activity in Vpu-expressing cells. We now report that Vpu, through its interaction with TrCP, potently contributes to the induction of apoptosis in HIV-infected T cells. Vpu-induced apoptosis is specific and independent of other viral proteins. Mutation of a TrCP-binding motif in Vpu abolishes its apoptogenic property, demonstrating a close correlation between this property of Vpu and its ability to inhibit NF-kappaB activity. The involvement of NF-kappaB in Vpu-induced apoptosis is further supported by the finding that the levels of antiapoptotic factors Bcl-xL, A1/Bfl-1, and TNF receptor-associated factor (TRAF)1, all of which are expressed in an NF-kappaB-dependent manner, are reduced and, at the same time, levels of active caspase-3 are elevated. Thus, Vpu induces apoptosis through activation of the caspase pathway by way of inhibiting the NF-kappaB-dependent expression of antiapoptotic genes.
Assuntos
Apoptose , HIV-1/metabolismo , NF-kappa B/metabolismo , Biossíntese de Proteínas , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Proteínas Virais Reguladoras e Acessórias/metabolismo , Sítios de Ligação , Antígenos CD4/genética , Linfócitos T CD4-Positivos/citologia , Linfócitos T CD4-Positivos/efeitos dos fármacos , Linfócitos T CD4-Positivos/metabolismo , Caspase 3 , Caspases/metabolismo , Linhagem Celular Transformada , Ativação Enzimática , Proteínas de Ligação ao GTP/metabolismo , Expressão Gênica , Produtos do Gene env/metabolismo , HIV-1/fisiologia , Células HeLa , Proteínas do Vírus da Imunodeficiência Humana , Humanos , Células Jurkat , Antígenos de Histocompatibilidade Menor , Peptídeo Sintases/metabolismo , Proteínas Recombinantes de Fusão/genética , Proteínas Ligases SKP Culina F-Box , Fator 1 Associado a Receptor de TNF , Fator de Necrose Tumoral alfa/farmacologia , Proteínas Virais Reguladoras e Acessórias/genética , Proteínas Virais Reguladoras e Acessórias/fisiologia , Proteína bcl-X , Proteínas Contendo Repetições de beta-TransducinaRESUMO
A 16-kilodalton protein expressed in cells producing the human immunodeficiency virus (HIV-1) was identified as the gene product of the vpu open reading frame. When expressed in vitro, the 81-amino acid vpu protein reacted with about one-third of the serum samples from AIDS patients that were tested, indicating that the vpu open reading frame is expressed in vivo as well. Introduction of a frame-shift mutation into the vpu open reading frame did not significantly interfere with expression of the major viral proteins in a transient expression system. However, a five- to tenfold reduction in progeny virions was observed after the infection of T lymphocytes with the mutant virus. These data suggest that the vpu gene product is required for efficient virus replication and may have a role in assembly or maturation of progeny virions.
Assuntos
Genes Virais , HIV/genética , Proteínas Virais/genética , Síndrome da Imunodeficiência Adquirida/imunologia , Sequência de Bases , DNA Viral/genética , Eletroforese em Gel de Poliacrilamida , HIV/fisiologia , Humanos , Soros Imunes/imunologia , Imunoensaio , Mutação , Biossíntese de Proteínas , RNA Viral/genética , Linfócitos T/microbiologia , Transcrição Gênica , Proteínas Virais/imunologia , Proteínas Virais/fisiologia , Replicação ViralRESUMO
Major histocompatibility complex (MHC) class I molecules are the major receptors for viral peptides and serve as targets for specific cytotoxic T lymphocytes. Human immunodeficiency virus-type 1 (HIV-1) specifically decreased activity of an MHC class I gene promoter up to 12-fold. Repression was effected by the HIV-1 Tat protein derived from a spliced viral transcript (two-exon Tat). These studies define an activity for two-exon Tat distinct from that of one-exon Tat and suggest a mechanism whereby HIV-1-infected cells might be able to avoid immune surveillance, allowing the virus to persist in the infected host.
Assuntos
Regulação da Expressão Gênica , Produtos do Gene tat/genética , Genes MHC Classe I/genética , HIV-1/genética , Regiões Promotoras Genéticas , Éxons , Produtos do Gene tat/fisiologia , Genes tat , Células HeLa , Humanos , Sequências Reguladoras de Ácido Nucleico , Transfecção , Produtos do Gene tat do Vírus da Imunodeficiência HumanaRESUMO
The human immunodeficiency virus type 1 (HIV-1) encoded Vpu is a small integral membrane phosphoprotein that functions in the enhancement of viral particle release and has more recently been shown to cause degradation of CD4 at the endoplasmic reticulum. We have demonstrated earlier that Vpu is phosphorylated by the ubiquitous casein kinase-2 (CK-2) in HIV-1 infected cells. The phosphoacceptor sites targeted by CK-2 in Vpu, however, have not been demonstrated and it was unclear whether Vpu was phosphorylated at one or more of its four serine residues. In this study we characterized the CK-2 phosphoacceptor sites in Vpu using recombinant CK-2 for in vitro phosphorylation of recombinant Vpu protein as well as synthetic peptides of Vpu. Phosphorylation of both Ser52 and Ser56 was demonstrated by in vitro phosphorylation using three 54-residue peptides comprising the entire hydrophilic part of Vpu and containing single serine to asparagine transitions in either position 52 or 56. The Km values of CK-2 to these peptides were established, revealing a preferential phosphorylation of Ser56. The Km values are: Ser56 = 31 microM; Ser 52 = 156 microM; wild type = 27 microM. In addition, we studied phosphorylation of Vpu by endogenous CK-2 following in vitro translation in rabbit reticulocyte lysate of wild-type Vpu or a mutant, Vpum2/6, carrying serine to asparagine changes at amino acid positions 52 and 56. The in vivo phosphorylation of Vpu was studied in transiently transfected human embryonic kidney (293) cells. In this system, the mutant Vpum2/6 was not phosphorylated, indicating that the seryl residues of Vpu at amino acid positions 52 and 56, but not those at positions 23 and 61, are phosphorylated by CK-2. The two CK-2 phosphorylation sites are conserved in all known Vpu sequences and represent the consensus Ser52GlyAsn(Glu/Asp)Ser(Glu/Asp)Gly(Glu/Asp)59. Prediction of the secondary structure revealed a conserved alpha-helix-turn-alpha-helix motif for the hydrophilic C-terminal part of Vpu. A structural model for Vpu is proposed in which the membrane anchor precedes a region comprising two amphipathic alpha-helices of opposed polarity, joined by a strongly acidic turn that protrudes into the cytoplasm and contains the CK-2 phosphorylation sites. Possible functional and structural homologies of Vpu to the membrane channel-forming M2 protein of influenza A viruses are discussed.
Assuntos
HIV-1/metabolismo , Proteínas Quinases/metabolismo , Estrutura Secundária de Proteína , Serina , Proteínas Virais Reguladoras e Acessórias/química , Proteínas Virais Reguladoras e Acessórias/metabolismo , Sequência de Aminoácidos , Sequência de Bases , Caseína Quinases , Primers do DNA , Proteínas do Vírus da Imunodeficiência Humana , Humanos , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Fosforilação , Reação em Cadeia da Polimerase , Biossíntese de Proteínas , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Reticulócitos/metabolismo , Proteínas Virais Reguladoras e Acessórias/biossínteseRESUMO
HIV-1 Vpu catalyzes two independent functions, degradation of the virus receptor CD4 in the endoplasmic reticulum and enhancement of virus release from the cell surface. These activities are confined to distinct structural domains of Vpu, the cytoplasmic tail and the transmembrane (TM) anchor, respectively. It was recently reported that Vpu forms cation-selective ion channels in lipid bilayers. Here we report that this property of Vpu is a characteristic of its TM anchor. Expression of full-length Vpu in Xenopus oocytes increases membrane conductance. The Vpu-induced conductance is selective to monovalent cations over anions, does not discriminate Na+ over K+ and shows marginal permeability to divalent cations. Notably, introduction of the scrambled TM sequence into full-length Vpu abrogates its capacity to increase membrane conductance in oocytes and to promote virus release from infected cells. Reconstitution of synthetic Vpu fragments in lipid bilayers identified an ion channel activity for a sequence corresponding to the TM domain of Vpu. In contrast, a peptide with the same amino acid composition but with a scrambled sequence does not form ion channels. Our findings therefore suggest that the ability of Vpu to increase virus release from infected cells may be correlated with an ion channel activity of the TM domain, thereby providing a potential target for drug intervention based on the development of Vpu-specific channel blockers.
Assuntos
Membrana Celular/metabolismo , HIV-1/metabolismo , Canais Iônicos/metabolismo , Oócitos/virologia , Proteínas Virais Reguladoras e Acessórias/metabolismo , Sequência de Aminoácidos , Animais , Sítios de Ligação , Cátions/metabolismo , Membrana Celular/virologia , Permeabilidade da Membrana Celular , Eletrofisiologia , Feminino , HIV-1/química , Proteínas do Vírus da Imunodeficiência Humana , Bicamadas Lipídicas , Dados de Sequência Molecular , Oócitos/metabolismo , Oócitos/ultraestrutura , Conformação Proteica , Proteínas Virais Reguladoras e Acessórias/química , Proteínas Virais Reguladoras e Acessórias/genética , XenopusRESUMO
The present study was undertaken to examine structural features of L-chicoric acid (3) which are important for potency against purified HIV-1 integrase and for reported cytoprotective effects in cell-based systems. Through a progressive series of analogues, it was shown that enantiomeric D-chicoric acid (4) retains inhibitory potency against purified integrase equal to its L-counterpart and further that removal of either one or both carboxylic functionalities results in essentially no loss of inhibitory potency. Additionally, while two caffeoyl moieties are required, attachment of caffeoyl groups to the central linking structure can be achieved via amide or mixed amide/ester linkages. More remarkable is the finding that blockage of the catechol functionality through conversion to tetraacetate esters results in almost no loss of potency, contingent on the presence of at least one carboxyl group on the central linker. Taken as a whole, the work has resulted in the identification of new integrase inhibitors which may be regarded as bis-caffeoyl derivatives of glycidic acid and amino acids such as serine and beta-aminoalanine. The present study also examined the reported ability of chicoric acid to exert cytoprotective effects in HIV-infected cells. It was demonstrated in target and cell-based assays that the chicoric acids do not significantly inhibit other targets associated with HIV-1 replication, including reverse transcription, protease function, NCp7 zinc finger function, or replication of virus from latently infected cells. In CEM cells, for both the parent chicoric acid and selected analogues, antiviral activity was observable under specific assay conditions and with high dependence on the multiplicity of viral infection. However, against HIV-1- and HIV-2-infected MT-4 cells, the chicoric acids and their tetraacetylated esters exhibited antiviral activity (50% effective concentration (EC50) ranging from 1.7 to 20 microM and 50% inhibitory concentration (IC50) ranging from 40 to 60 microM).
Assuntos
Fármacos Anti-HIV/farmacologia , Ácidos Cafeicos , Inibidores de Integrase de HIV/farmacologia , Integrase de HIV/metabolismo , Succinatos/síntese química , Animais , Linhagem Celular , Avaliação Pré-Clínica de Medicamentos , HIV-1/efeitos dos fármacos , HIV-2/efeitos dos fármacos , Humanos , Estereoisomerismo , Relação Estrutura-Atividade , Succinatos/química , Succinatos/farmacologia , Replicação Viral/efeitos dos fármacosAssuntos
Produtos do Gene nef/fisiologia , Produtos do Gene vif/fisiologia , Produtos do Gene vpr/fisiologia , HIV-1/fisiologia , Proteínas Virais Reguladoras e Acessórias/fisiologia , Antígenos CD4/análise , Ciclo Celular , Citoesqueleto/química , Antígenos de Histocompatibilidade Classe I/análise , Proteínas do Vírus da Imunodeficiência Humana , Transativadores/fisiologia , Produtos do Gene nef do Vírus da Imunodeficiência Humana , Produtos do Gene vif do Vírus da Imunodeficiência Humana , Produtos do Gene vpr do Vírus da Imunodeficiência HumanaRESUMO
The human immunodeficiency virus type 1 (HIV-1)-specific Vpu is an 81-amino-acid amphipathic integral membrane protein with at least two different biological functions: (i) enhancement of virus particle release from the plasma membrane of HIV-1-infected cells and (ii) degradation of the virus receptor CD4 in the endoplasmic reticulum (ER). We have previously found that Vpu is phosphorylated in infected cells at two seryl residues in positions 52 and 56 by the ubiquitous casein kinase 2. To study the role of Vpu phosphorylation on its biological activity, a mutant of the vpu gene lacking both phosphoacceptor sites was introduced into the infectious molecular clone of HIV-1, pNL4-3, as well as subgenomic Vpu expression vectors. This mutation did not affect the expression level or the stability of Vpu but had a significant effect on its biological activity in infected T cells as well as transfected HeLa cells. Despite the presence of comparable amounts of wild-type and nonphosphorylated Vpu, decay of CD4 was observed only in the presence of phosphorylated wild-type Vpu. Nonphosphorylated Vpu was unable to induce degradation of CD4 even if the proteins were artificially retained in the ER. In contrast, Vpu-mediated enhancement of virus secretion was only partially dependent on Vpu phosphorylation. Enhancement of particle release by wild-type Vpu was efficiently blocked when Vpu was artificially retained in the ER, suggesting that the two biological functions of Vpu are independent, occur at different sites within a cell, and exhibit different sensitivity to phosphorylation.
Assuntos
Compartimento Celular , HIV-1/crescimento & desenvolvimento , Processamento de Proteína Pós-Traducional , Proteínas Virais Reguladoras e Acessórias/metabolismo , Sequência de Bases , Transporte Biológico , Antígenos CD4/metabolismo , Retículo Endoplasmático/metabolismo , Células HeLa/microbiologia , Proteínas do Vírus da Imunodeficiência Humana , Humanos , Dados de Sequência Molecular , Fosforilação , Proteínas Quinases/metabolismo , Processamento de Proteína Pós-Traducional/genética , Sequências Reguladoras de Ácido Nucleico/genética , Linfócitos T/microbiologia , Proteínas Virais Reguladoras e Acessórias/genéticaRESUMO
Foot-and-mouth disease virus (FMDV) genes are expressed as a polyprotein which is rapidly processed into the four primary cleavage products L, P1, P2, and P3. In secondary cleavage reactions, these are further processed into the mature proteins. The FMDV L protein is located at the N terminus of the polyprotein and is the first gene product released from the nascent polyprotein. For analysis of its biological function, the L gene was mutated by site-directed mutagenesis of cloned cDNA. In vitro translation of in vitro transcripts of these DNAs and expression studies in Escherichia coli showed that the L mutants affect the processing of the viral polyprotein. The mutants isolated were partially or totally defective in processing the polyprotein at the L/P1 junction. These mutants could, however, be processed in the presence of the wild-type L protein. Furthermore, an antiserum directed against the L protein inhibited processing at the L/P1 cleavage site, so that the release of the L protein from the polyprotein was blocked. These data reveal that the L gene product represents a viral protease which catalyzes its own release from the nascent polyprotein.
Assuntos
Aphthovirus/enzimologia , Peptídeo Hidrolases/análise , Proteínas Virais/análise , Animais , Genes Virais , Soros Imunes/imunologia , Mutação , Peptídeo Hidrolases/genética , Peptídeo Hidrolases/imunologia , Plasmídeos , Biossíntese de Proteínas , Processamento de Proteína Pós-Traducional , Coelhos , Reticulócitos/metabolismo , Proteínas do Envelope Viral/metabolismo , Proteínas Virais de FusãoRESUMO
We have recently shown that the envelope glycoprotein of the ROD10 isolate of human immunodeficiency virus type 2 (HIV-2) has the ability to positively regulate HIV-2 viral particle release. The activity provided by the ROD10 Env was remarkably similar to that of the HIV-1 Vpu protein, thus raising the possibility that the two proteins act in a related fashion. We now show that the ROD10 Env can functionally replace Vpu to enhance the rate of HIV-1 particle release. When provided in trans, both Vpu and the ROD10 Env restored wild-type levels of particle release in a Vpu-deficient mutant of the NL4-3 molecular clone with indistinguishable efficiencies. This effect was independent of the presence of the HIV-1 envelope protein. The ROD10 Env also enhanced HIV-1 particle release in the context of HIV-2 chimeric viruses containing the HIV-1 gag-pol, indicating a lack of need for additional HIV-1 products in this process. In addition, we show for the first time that HIV-1 Vpu, as well as ROD10 Env, has the ability to enhance simian immunodeficiency virus (SIV) particle release. The effects of Vpu and ROD10 Env on SIV particle release were indistinguishable and were observed in the context of full-length SIVmac239 and simian-human immunodeficiency virus chimeras. These results further demonstrate that ROD10 Env can functionally complement Vpu with respect to virus release. In contrast, we found no evidence of a destabilizing activity of ROD10 Env on the CD4 molecule. HIV-1 and HIV-2 thus appear to have evolved genetically distinct but functionally similar strategies to resolve the common problem of efficient release of progeny virus from infected cells.
Assuntos
Produtos do Gene env/metabolismo , HIV-1/metabolismo , HIV-2/metabolismo , Precursores de Proteínas/metabolismo , Proteínas Virais Reguladoras e Acessórias/metabolismo , Animais , Antígenos CD4/imunologia , Regulação Viral da Expressão Gênica , Produtos do Gene env/genética , Produtos do Gene env/imunologia , HIV-1/genética , HIV-1/fisiologia , HIV-2/genética , Células HeLa , Proteínas do Vírus da Imunodeficiência Humana , Humanos , Precursores de Proteínas/genética , Precursores de Proteínas/imunologia , Coelhos , Vírus Reordenados/genética , Vírus Reordenados/metabolismo , Vírus Reordenados/fisiologia , Proteínas Virais Reguladoras e Acessórias/genética , Montagem de Vírus , Produtos do Gene env do Vírus da Imunodeficiência HumanaRESUMO
We have recently demonstrated that coexpression of Vpu and CD4 in HeLa cells results in the degradation of CD4 in the endoplasmic reticulum. The sensitivity of CD4 to Vpu-mediated degradation is conferred by the presence of specific sequences located between amino acids 402 and 420 in the CD4 cytoplasmic domain. Using an in vitro translation system, we also showed that degradation of CD4 by Vpu requires the two proteins to be present in the same membrane compartment. Although these results suggest that spatial proximity between CD4 and Vpu may be critical in triggering degradation, it remains unknown whether the two molecules have the ability to interact with each other. In order to better define the mechanisms involved in CD4 degradation, we investigated the existence and functional relevance of direct interactions between CD4 and Vpu. Coimmunoprecipitation experiments showed that Vpu specifically binds to the cytoplasmic tail of CD4. This phenomenon is relevant to the mechanism of CD4 degradation since the ability of CD8/CD4 chimeric molecules and various CD4 mutants to form complexes with Vpu correlates with their sensitivity to degradation. Accordingly, we found that amino acid residues in the CD4 cytoplasmic tail previously shown to be important for degradation are necessary for Vpu binding. We further demonstrate that a deletion mutant of Vpu as well as a phosphorylation mutant, both biologically inactive with regard to CD4 degradation, retained the capacity to interact with the CD4 cytoplasmic domain. Taken together, these results indicate that Vpu binding is necessary to trigger CD4 degradation. However, the binding to target molecules is not sufficient per se to cause degradation. Interaction between CD4 and Vpu is thus likely to be an early event critical in triggering a multistep process leading to CD4 degradation.
Assuntos
Antígenos CD4/metabolismo , HIV-1/metabolismo , Proteínas Virais Reguladoras e Acessórias/metabolismo , Sequência de Aminoácidos , Citoplasma/metabolismo , Retículo Endoplasmático/metabolismo , Células HeLa , Proteínas do Vírus da Imunodeficiência Humana , Humanos , Técnicas In Vitro , Dados de Sequência Molecular , Fosforilação , Ligação Proteica , Proteínas Recombinantes de Fusão/metabolismo , Proteínas Recombinantes , Relação Estrutura-AtividadeRESUMO
Proteolytic changes in the muscles of cadaver are demonstrable by putrefaction experiment with the electrofocusing on polyacrylamide gels. These changes can--within a narrow limit--be used in the determination of time of death at a stage when the early signs of death are not suitable any more. A fraction with a pI-value of 7.2 appears as a proteolytic fission at 30 degrees C not earlier than the second day after death. This fraction can be detected at 20 degrees C from the fifth to the sixth day p.m. At 10 degrees C it will not be detectable until the ninth day p.m. At a pH-range between 6.9 and 7.7, at 30 degrees C and 8 days after death, or at 20 degrees C and 9 days after death, only a relatively stable fraction is detectable with a pI-value between 6.9 and 7.0.
Assuntos
Medicina Legal , Focalização Isoelétrica , Proteínas Musculares/análise , Humanos , Mudanças Depois da Morte , TemperaturaRESUMO
The human immunodeficiency virus type 1 (HIV-1) Vif protein has an important role in the regulation of virus infectivity. This function of Vif is cell type specific, and virions produced in the absence of Vif in restrictive cells have greatly reduced infectivity. We show here that the intracellular localization of Vif is dependent on the presence of the intermediate filament vimentin. Fractionation of acutely infected T cells or transiently transfected HeLa cells demonstrates the existence of a soluble and a cytoskeletal form and to a lesser extent the presence of a detergent-extractable form of Vif. Confocal microscopy suggests that in HeLa cells, Vif is predominantly present in the cytoplasm and closely colocalizes with the intermediate filament vimentin. Treatment of cells with drugs affecting the structure of vimentin filaments affect the localization of Vif accordingly, indicating a close association of Vif with this cytoskeletal component. The association of Vif with vimentin can cause the collapse of the intermediate filament network into a perinuclear aggregate. In contrast, analysis of Vif in vimentin-negative cells reveals significant staining of the nucleus and the nuclear membrane in addition to diffuse cytoplasmic staining. In addition to the association of Vif with intermediate filaments, analyses of virion preparations demonstrate that Vif is incorporated into virus particles. In sucrose density gradients, Vif cosediments with capsid proteins even after detergent treatment of virus preparations, suggesting that Vif is associated with the inner core of HIV particles. We propose a model in which Vif has a crucial function as a virion component either by regulating virus maturation or following virus entry into a host cell possibly involving an interaction with the cellular cytoskeletal network.
Assuntos
Citoesqueleto/virologia , Produtos do Gene vif/metabolismo , HIV-1/metabolismo , Vimentina/metabolismo , Animais , Sequência de Bases , Linhagem Celular , Citoesqueleto/metabolismo , DNA Viral , Soropositividade para HIV/sangue , Soropositividade para HIV/imunologia , Células HeLa , Humanos , Dados de Sequência Molecular , Células Tumorais Cultivadas , Vírion/metabolismo , Produtos do Gene vif do Vírus da Imunodeficiência HumanaRESUMO
One of the hallmarks of human immunodeficiency virus type I (HIV-1) infection is the rapid removal of the viral receptor CD4 from the cell surface. This remarkably efficient receptor interference requires the activity of three separate viral proteins: Env, Vpu, and Nef. We have investigated whether this unusually tight interference on cell surface CD4 expression had a more essential function during the viral life cycle than simply preventing superinfection. We now report that the removal of cell surface CD4 is required for optimal virus production by HIV-1. Indeed, maintenance of CD4 surface expression in infected cells lead to a 3-5-fold decrease in viral particle production. This effect was not due to the formation of intracellular complexes between CD4 and the gp160 viral envelope precursor but instead required the presence of CD4 at the cell surface and was specifically mediated by CD4 but not closely related plasma membrane receptors. The finding that CD4 had no significant effect on particle release by a Vpu-deficient variant indicates that CD4 acts by inhibiting the particle release-promoting activity of Vpu. Co-immunoprecipitation experiments further showed that CD4 and Vpu physically interact at the cell surface, suggesting that CD4 might inhibit Vpu activity by disrupting its oligomeric structure.
Assuntos
Antígenos de Superfície/fisiologia , Antígenos CD4/fisiologia , HIV-1/fisiologia , Proteínas Virais Reguladoras e Acessórias/antagonistas & inibidores , Vírion/fisiologia , Membrana Celular/imunologia , Membrana Celular/virologia , Citoplasma/imunologia , Células HeLa , Proteínas do Vírus da Imunodeficiência Humana , HumanosRESUMO
The human immunodeficiency virus type 1 (HIV-1) Vpu and Env proteins are expressed from a bicistronic mRNA. To address the biological significance of the coordinated expression of vpu and env, we compared the relative effects on particle release of HIV-1 isolates containing an intact vpu gene or carrying point mutations in its initiation codon or internal deletions, respectively. We found that the primary AD8 isolate, which is unable to express vpu due to a mutation in its translation initiation codon, was able to replicate in primary macrophages and peripheral blood mononuclear cells with efficiency similar to that of an isogenic variant expressing Vpu. Interestingly, AD8 lacking a vpu initiation codon produced higher levels of Env protein than its Vpu-expressing isogenic variant. In contrast, disabling Vpu without removing the vpu initiation codon did not alter Env expression but significantly reduced virus production. AD8 Env when provided in trans was capable of enhancing release not only of AD8 particles but also of viruses of the T-cell-tropic NL4-3 isolate. We conclude that AD8 Env encodes a Vpu-like activity similar to that previously reported for HIV-2 Env proteins and is thus able to augment virus secretion. When expressed at elevated levels, i.e., following mutation of the vpu initiation codon, AD8 Env was able to compensate for the lack of Vpu and thereby ensure efficient virus release. Thus, the ability to regulate virus release is redundant in AD8 and can be controlled by either Vpu or Env. Since Vpu controls several independent functions, including CD4 degradation, our results suggest that some HIV-1 isolates may have evolved a mechanism to regulate Vpu activity without compromising their ability to efficiently replicate in the host cells.
Assuntos
Produtos do Gene env/fisiologia , HIV-1/fisiologia , Macrófagos/virologia , Proteínas Virais Reguladoras e Acessórias/fisiologia , Sequência de Aminoácidos , Sequência de Bases , Células Cultivadas , Expressão Gênica , Produtos do Gene env/biossíntese , HIV-1/genética , HIV-1/isolamento & purificação , Células HeLa , Proteínas do Vírus da Imunodeficiência Humana , Humanos , Leucócitos Mononucleares/citologia , Leucócitos Mononucleares/virologia , Macrófagos/citologia , Dados de Sequência Molecular , Mutagênese , Transfecção , Proteínas Virais Reguladoras e Acessórias/genética , Replicação ViralRESUMO
In addition to its role in receptor binding, the envelope glycoprotein of certain human immunodeficiency virus type 2 (HIV-2) isolates, including ROD10, exhibits a biological activity that enhances the release of HIV-2, HIV-1, and simian immunodeficiency virus particles from infected cells. The present study aims at better defining the functional domains involved in this biological activity. To this end, we have characterized the envelope protein of the ROD14 isolate of HIV-2, which, despite 95% homology with the ROD10 envelope at the amino acid level, is unable to enhance viral particle release. Site-directed mutagenesis showed that the presence of a truncation in the cytoplasmic tail of the ROD14 envelope was not responsible for the lack of activity, as previously reported for the HIV-2 ST isolate (G. D. Ritter, Jr., G. Yamshchikov, S. J. Cohen, and M. J. Mulligan, J. Virol. 70:2669-2673, 1996). Similarly, several modifications of the length of the ROD10 envelope cytoplasmic tail did not impair its ability to enhance particle release, suggesting that, in the case of the HIV-2 ROD isolate, particle release activity is not regulated by the length of the cytoplasmic tail.
Assuntos
Produtos do Gene env/fisiologia , Herpesvirus Humano 2/fisiologia , Vírion/fisiologia , Sequência de Aminoácidos , Citoplasma , Produtos do Gene env/química , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Relação Estrutura-AtividadeRESUMO
CD4 is an integral membrane glycoprotein which functions as the human immunodeficiency virus receptor for infection of human host cells. We have recently demonstrated that Vpu, a human immunodeficiency virus type 1-encoded integral membrane phosphoprotein, induces rapid degradation of CD4 in the endoplasmic reticulum. Using an in vitro model system, we demonstrated that Vpu targets specific sequences in the cytoplasmic domain of CD4 to promote its degradation. In this report, we have further delineated regions within CD4 which are required for susceptibility to Vpu. Transfer of the CD4 cytoplasmic region into a heterologous protein, CD8, rendered the chimeric protein sensitive to Vpu-dependent degradation. In contrast, substitution of the CD8 transmembrane domain with the analogous region from CD4 did not confer sensitivity to Vpu. Finally, mutant forms of the CD4 protein containing the extracellular region alone or the extracellular and transmembrane regions linked to a heterologous cytoplasmic domain were not targeted by Vpu. Thus, sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to Vpu.
Assuntos
Antígenos CD4/metabolismo , HIV-1/metabolismo , Proteínas Virais Reguladoras e Acessórias/metabolismo , Sequência de Aminoácidos , Sequência de Bases , Antígenos CD4/genética , Antígenos CD8/genética , Antígenos CD8/metabolismo , Células HeLa , Proteínas do Vírus da Imunodeficiência Humana , Humanos , Dados de Sequência Molecular , Proteínas Recombinantes de Fusão/metabolismo , Homologia de Sequência de Aminoácidos , Relação Estrutura-Atividade , TransfecçãoRESUMO
We have performed a detailed analysis of the biochemical properties of the human immunodeficiency virus (HIV) type 1 vpu gene product to elucidate its function during virus replication. Our data suggest that vpu is posttranslationally modified by phosphorylation, since a 16-kilodalton phosphoprotein can be specifically immunoprecipitated with both a serum from an HIV-positive individual (HIV-positive serum) and a vpu-specific antiserum. In contrast, our results suggest that vpu is not glycosylated, even though the protein contains a potential glycosylation site. In vitro translation studies demonstrated that vpu is cotranslationally integrated into microsomal membranes, suggesting that vpu is an integral membrane protein. While vpu was found in significant quantities in virus-producing cells, the protein could not be detected in cell-free culture fluids and is therefore most likely not viron associated. Processing of viral precursor proteins was unaffected by the absence of vpu, and no differences were detected in the protein compositions of wild-type and mutant virions. However, virus release from cultures producing vpu-defective virus was found to be delayed, resulting in the intracellular accumulation of viral proteins. Our data suggest that vpu has a function in the release of virus particles from infected cells.
Assuntos
HIV/análise , Proteínas Virais/análise , Sequência de Bases , Humanos , Proteínas de Membrana/análise , Dados de Sequência Molecular , Processamento de Proteína Pós-Traducional , Proteínas Virais/fisiologiaRESUMO
Defined segments of the cloned foot-and-mouth disease virus genome corresponding to all parts of the coding region were expressed in Escherichia coli as fusions to the N-terminal part of the MS2-polymerase gene under the control of the inducible lambda PL promoter. All constructs yielded large amounts of proteins, which were purified and used to raise sequence-specific antisera in rabbits. These antisera were used to identify the corresponding viral gene products in 35S-labeled extracts from foot-and-mouth disease virus gene products in the nucleotide sequence, to identify precursor-product relationships, and to detect several foot-and-mouth disease virus gene products not previously identified in vivo or in vitro.